Cartesian Therapeutics, Inc. Paid-in-Kind Interest
Cartesian Therapeutics, Inc. (RNAC) reported Paid-in-Kind Interest of $355.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2026-08-06
- Cartesian Therapeutics, Inc. paid-in-kind interest for the quarter ending 2024-12-31 was $0.00.
- Cartesian Therapeutics, Inc. paid-in-kind interest for the quarter ending 2024-09-30 was $0.00.
- Cartesian Therapeutics, Inc. paid-in-kind interest for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Cartesian Therapeutics, Inc. paid-in-kind interest for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Cartesian Therapeutics, Inc. paid-in-kind interest for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Cartesian Therapeutics, Inc. paid-in-kind interest for fiscal 2023 was $455.00K, a 52.26% decline from fiscal 2022.
- Cartesian Therapeutics, Inc. paid-in-kind interest for fiscal 2022 was $953.00K, a 5.83% decline from fiscal 2021.
- Cartesian Therapeutics, Inc. paid-in-kind interest for fiscal 2021 was $1.01M, a 63.23% increase from fiscal 2020.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $355.00K 10-Q · filed 2026-08-06 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $0.00 derived: sum of 2 quarters · filed 2025-03-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-13 | $0.00 10-K · filed 2025-03-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2025-03-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-03-13 | -$78.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-03-13 | -$78.00K derived: sum of 3 quarters · filed 2025-03-13 | $57.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$78.00K derived: sum of 2 quarters · filed 2025-03-13 | $57.00K derived: sum of 3 quarters · filed 2025-03-13 | $455.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | -$78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $57.00K derived: sum of 2 quarters · filed 2024-11-07 | $455.00K 10-Q · filed 2024-11-07 | $631.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $533.00K 10-Q · filed 2024-08-08 | $709.00K derived: sum of 3 quarters · filed 2024-08-08 | $907.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $398.00K 10-Q · filed 2024-05-08 | $574.00K derived: sum of 2 quarters · filed 2024-05-08 | $772.00K derived: sum of 3 quarters · filed 2024-05-08 | $968.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $374.00K derived: sum of 2 quarters · filed 2024-03-07 | $570.00K derived: sum of 3 quarters · filed 2024-03-07 | $953.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $394.00K derived: sum of 2 quarters · filed 2023-11-13 | $777.00K 10-Q · filed 2023-11-13 | $989.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-17 | $579.00K 10-Q · filed 2023-08-17 | $791.00K derived: sum of 3 quarters · filed 2024-03-07 | $997.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $383.00K 10-Q · filed 2023-05-04 | $595.00K derived: sum of 2 quarters · filed 2024-03-07 | $801.00K derived: sum of 3 quarters · filed 2024-03-07 | $1.01M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $418.00K derived: sum of 2 quarters · filed 2024-03-07 | $625.00K derived: sum of 3 quarters · filed 2024-03-07 | $1.01M 10-K · filed 2024-03-07 |
| 2021-09-30 | $206.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $413.00K derived: sum of 2 quarters · filed 2022-11-03 | $800.00K 10-Q · filed 2022-11-03 | $1.01M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $594.00K 10-Q · filed 2022-08-08 | $808.00K derived: sum of 3 quarters · filed 2023-03-02 | $1.04M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $387.00K 10-Q · filed 2022-05-05 | $601.00K derived: sum of 2 quarters · filed 2023-03-02 | $834.00K derived: sum of 3 quarters · filed 2023-03-02 | $884.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $447.00K derived: sum of 2 quarters · filed 2023-03-02 | $497.00K derived: sum of 3 quarters · filed 2023-03-02 | $620.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $283.00K derived: sum of 2 quarters · filed 2021-11-09 | $406.00K 10-Q · filed 2021-11-09 | $470.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $173.00K 10-Q · filed 2021-08-12 | $237.00K derived: sum of 3 quarters · filed 2022-03-10 | $308.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $123.00K 10-Q · filed 2021-05-13 | $187.00K derived: sum of 2 quarters · filed 2022-03-10 | $258.00K derived: sum of 3 quarters · filed 2022-03-10 | $336.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $135.00K derived: sum of 2 quarters · filed 2022-03-10 | $213.00K derived: sum of 3 quarters · filed 2022-03-10 | $402.00K 10-K · filed 2022-03-10 |
| 2019-09-30 | $71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $149.00K derived: sum of 2 quarters · filed 2020-11-05 | $338.00K 10-Q · filed 2020-11-05 | $433.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $267.00K 10-Q · filed 2020-08-06 | $362.00K derived: sum of 3 quarters · filed 2021-03-12 | $451.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $189.00K 10-Q · filed 2020-05-07 | $284.00K derived: sum of 2 quarters · filed 2021-03-12 | $373.00K derived: sum of 3 quarters · filed 2021-03-12 | $461.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $184.00K derived: sum of 2 quarters · filed 2021-03-12 | $272.00K derived: sum of 3 quarters · filed 2021-03-12 | $449.00K 10-K · filed 2021-03-12 |
| 2018-09-30 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $177.00K derived: sum of 2 quarters · filed 2019-11-08 | $354.00K 10-Q · filed 2019-11-08 | $495.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $265.00K 10-Q · filed 2019-08-08 | $406.00K derived: sum of 3 quarters · filed 2020-03-12 | $451.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $177.00K 10-Q · filed 2019-05-09 | $318.00K derived: sum of 2 quarters · filed 2020-03-12 | $363.00K derived: sum of 3 quarters · filed 2020-03-12 | $423.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $186.00K derived: sum of 2 quarters · filed 2020-03-12 | $246.00K derived: sum of 3 quarters · filed 2020-03-12 | $390.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $105.00K derived: sum of 2 quarters · filed 2018-11-08 | $249.00K 10-Q · filed 2018-11-08 | $336.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $204.00K 10-Q · filed 2018-08-08 | $291.00K derived: sum of 3 quarters · filed 2019-03-15 | $359.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $144.00K 10-Q · filed 2018-05-09 | $231.00K derived: sum of 2 quarters · filed 2019-03-15 | $299.00K derived: sum of 3 quarters · filed 2019-03-15 | $366.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $155.00K derived: sum of 2 quarters · filed 2019-03-15 | $222.00K derived: sum of 3 quarters · filed 2019-03-15 | $263.00K 10-K · filed 2019-03-15 |
| 2016-09-30 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $135.00K derived: sum of 2 quarters · filed 2017-11-07 | $176.00K 10-Q · filed 2017-11-07 | $235.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $108.00K 10-Q · filed 2017-08-11 | $167.00K derived: sum of 3 quarters · filed 2018-03-15 | $118.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $41.00K 10-Q · filed 2017-05-11 | $100.00K derived: sum of 2 quarters · filed 2018-03-15 | $51.00K derived: sum of 3 quarters · filed 2018-03-15 | |
| 2015-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $10.00K derived: sum of 2 quarters · filed 2018-03-15 | $198.00K 10-K · filed 2018-03-15 | |
| 2015-09-30 | -$49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $139.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $188.00K 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $155.00K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |